Preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia patients taking the drug Imatinib mesylate (Gleevec).
Vaccine appears to ‘mop up’ leukemia cells Gleevec leaves behind
January 10th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.